https://orthotw.com/2026/09/vb-spine-announces-fda-breakthrough-device-designation-for-new-blood-test-designed-to-identify-patients-at-risk-for-scoliosis-progressionOrthopedics This Weeken2026-09-29T13:05:00.000ZVB Spine Announces FDA Breakthrough Device Designation for New Blood Test Designed to Identify Patients at Risk for Scoliosis Progression https://orthotw.com/2026/09/aclarion-welcomes-nyu-langone-health-to-clarity-trial-network-now-enrolling-at-eleven-sitesOrthopedics This Weeken2026-09-29T12:58:00.000ZAclarion Welcomes NYU Langone Health to CLARITY Trial Network, Now Enrolling at Eleven Sites https://orthotw.com/2026/09/si-bone-receives-fda-510-k-clearance-for-ifuse-granite-onyx-extending-its-compromised-bone-franchise-beyond-the-pelvis-fda-breakthrough-device-designated-bdd-platform-engineered-for-durable-fixation-in-low-density-boneOrthopedics This Weeken2026-09-29T12:40:00.000ZSI-BONE Receives FDA 510(k) Clearance for iFuse Granite Onyx™, Extending Its Compromised Bone Franchise Beyond the Pelvis FDA Breakthrough Device Designated (BDD) platform engineered for durable fixation in low density bone https://orthotw.com/2026/09/avesi-partners-announces-investment-in-new-age-medicalOrthopedics This Weeken2026-09-29T12:23:00.000ZAvesi Partners Announces Investment in New Age Medical https://orthotw.com/2026/09/bracing-for-prison-dme-owner-gets-13-months-in-medicare-kickback-caseOrthopedics This Weeken2026-09-29T11:58:00.000ZBracing for Prison: DME Owner Gets 13 Months in Medicare Kickback Case https://orthotw.com/2026/09/stryker-strong-growth-with-a-tariff-tailwind-in-the-profit-lineOrthopedics This Weeken2026-09-29T11:40:00.000ZStryker: Strong Growth, With a Tariff Tailwind in the Profit Line https://orthotw.com/2026/09/smith-nephew-sports-medicine-scores-knees-slow-the-teamOrthopedics This Weeken2026-09-29T11:30:00.000ZSmith&Nephew: Sports Medicine Scores; Knees Slow the Team https://orthotw.com/2026/09/kuros-magnetos-builds-sales-the-cash-label-needs-precisionOrthopedics This Weeken2026-09-29T11:19:00.000ZKuros: MagnetOs Builds Sales; the Cash Label Needs Precision https://orthotw.com/2026/09/malalignment-does-not-always-equate-to-poor-outcomesOrthopedics This Weeken2026-09-28T17:04:00.000ZMalalignment Does Not Always Equate to Poor Outcomes https://orthotw.com/2026/09/carlsmed-custom-implants-full-price-growthOrthopedics This Weeken2026-09-28T16:46:00.000ZCarlsmed: Custom Implants, Full-Price Growth https://orthotw.com/2026/09/curonix-announces-published-pns-impact-clinical-study-showing-freedom-peripheral-nerve-stimulatorOrthopedics This Weeken2026-09-28T14:51:00.000ZCuronix Announces Published PNS IMPACT Clinical Study Showing Freedom® Peripheral Nerve Stimulator (PNS) System is Associated with Reductions in Pain Scores, Opioid Use and Overall Patient Burden https://orthotw.com/2026/09/carlsmed-appoints-richard-heppenstall-as-chief-financial-officer-and-company-reaffirms-fiscal-year-2026-guidanceOrthopedics This Weeken2026-09-28T12:28:00.000ZCarlsmed Appoints Richard Heppenstall as Chief Financial Officer and Company Reaffirms Fiscal Year 2026 Guidance https://orthotw.com/2026/09/orthopediatrics-growing-up-with-cash-still-on-the-homework-listOrthopedics This Weeken2026-09-28T12:15:00.000ZOrthoPediatrics: Growing Up, With Cash Still on the Homework List https://orthotw.com/2026/09/pacira-more-sales-less-adjusted-ebitda-better-cashOrthopedics This Weeken2026-09-28T11:35:00.000ZPacira: More Sales, Less Adjusted EBITDA, Better Cash